Controversial Cattle Feed Additive Linked to Cancer Faces Global Expansion Despite FDA Concerns

Controversial Cattle Feed Additive Linked to Cancer Faces Global Expansion Despite FDA Concerns

A cattle feed additive associated with cancer risks and infertility is poised for widespread production and use, despite warnings from the U.S. Food and Drug Administration (FDA) that it is “not for human use.”

BlackRock-owned company ABB has been commissioned to construct a large new manufacturing plant in Scotland, aiming to increase the additive’s availability worldwide.

Known as Bovaer, this product is promoted as an environmentally friendly solution to reduce methane emissions from cattle and is currently in use on more than 150 farms across the United States.